Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein.

Vaccines (Basel) · 2023 · PMC10220924 · PMID 37243067

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Studies on poliomyelitis have also highlighted the superior immunity provided by fractional doses of intradermal immunization [ 9 ], which is highly significant for reaching as many people as possible in vaccine-deficient areas.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.